ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,791,262 | -42.5% | 1,259,476 | -30.4% | 0.37% | -44.3% |
Q2 2023 | $23,975,455 | -2.7% | 1,810,835 | 0.0% | 0.67% | -25.9% |
Q1 2023 | $24,645,464 | -30.3% | 1,810,835 | 0.0% | 0.90% | -39.7% |
Q4 2022 | $35,365,608 | +2.5% | 1,810,835 | 0.0% | 1.49% | +4.8% |
Q3 2022 | $34,496,000 | -13.2% | 1,810,835 | -6.1% | 1.42% | -25.7% |
Q2 2022 | $39,742,000 | -11.8% | 1,929,201 | +37.8% | 1.92% | +6.5% |
Q1 2022 | $45,058,000 | – | 1,400,201 | – | 1.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |